Stephen M. Davis

Stephen M. Davis

Auto-generated profile, based on publicly available information

Stephen M. Davis

The University of Melbourne, Royal Melbourne Hospital

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2006 in Neurology
Verified
Journal Article
Closed access
PDF file
SDS. M. Davis
S. M. Davis
JBJ. Broderick
J. Broderick
MHM. Hennerici
M. Hennerici
NBN. C. Brun
N. C. Brun
MDM. N. Diringer
M. N. Diringer
TST. Steiner
T. Steiner
Background: Although volume of intracerebral hemorrhage (ICH) is a predictor of mortality, it is unknown whether subsequent hematoma growth further increases the risk of death or poor functional outcome. Methods: To determine if hematoma growth independently predicts poor outcome, the authors performed an individual meta-analysis of patients with spontaneous ICH who had CT within 3 hours of onset and 24-hour follow-up. Placebo patients were pooled from three trials investigating dosing, safety, and efficacy of rFVIIa (n = 115), and 103 patients from the Cincinnati study (total 218). Other baseline factors included age, gender, blood glucose, blood pressure, Glasgow Coma Score (GCS), intraventricular hemorrhage (IVH), and location. Results: Overall, 72.9% of patients exhibited some degree of hematoma growth. Percentage hematoma growth (hazard ratio [HR] 1.05 per 10% increase [95% CI: 1.03, 1.08; p < 0.0001]), initial ICH volume (HR 1.01 per mL [95% CI: 1.00, 1.02; p = 0.003]), GCS (HR 0.88 [95% CI: 0.81, 0.96; p = 0.003]), and IVH (HR 2.23 [95% CI: 1.25, 3.98; p = 0.007]) were all associated with increased mortality. Percentage growth (cumulative OR 0.84 [95% CI: 0.75, 0.92; p < 0.0001]), initial ICH volume (cumulative OR 0.94 [95% CI: 0.91, 0.97; p < 0.0001]), GCS (cumulative OR 1.46 [95% CI: 1.21, 1.82; p < 0.0001]), and age (cumulative OR 0.95 [95% CI: 0.92, 0.98; p = 0.0009]) predicted outcome modified Rankin Scale. Gender, location, blood glucose, and blood pressure did not predict outcomes. Conclusions: Hematoma growth is an independent determinant of both mortality and functional outcome after intracerebral hemorrhage. Attenuation of growth is an important therapeutic strategy.

1 April 2008 in The Lancet Neurology
Verified
Journal Article
Closed access
SDStephen M Davis
Stephen M Davis
GDGeoffrey Donnan
Geoffrey Donnan
MPMark W Parsons
Mark W Parsons
CLChristopher Levi
Christopher Levi
KBKenneth S Butcher
Kenneth S Butcher
PDPatricia M Desmond
Patricia M Desmond

1 September 2003 in Stroke
Verified
Journal Article
Closed access
TBTracey A. Baird
Tracey A. Baird
MPMark W. Parsons
Mark W. Parsons
TPThanh Phan
Thanh Phan
KBKen S. Butcher
Ken S. Butcher
PDPatricia M. Desmond
Patricia M. Desmond
SDStephen M. Davis
Stephen M. Davis
Background and Purpose— Hyperglycemia at the time of ischemic stroke is associated with increased mortality and morbidity. Animal studies suggest that infarct expansion may be responsible. The influence of persisting hyperglycemia after stroke has not previously been examined. We measured the blood glucose profile after acute ischemic stroke and correlated it with infarct volume changes using T2- and diffusion-weighted MRI. Methods— We recruited 25 subjects within 24 hours of ischemic stroke symptoms. Continuous glucose monitoring was performed with a glucose monitoring device (CGMS), and 4-hour capillary glucose levels (BGL) were measured for 72 hours after admission. MRI and clinical assessments were performed at acute (median, 15 hours), subacute (median, 5 days), and outcome (median, 85 days) time points. Results— Mean CGMS glucose and mean BGL glucose correlated with infarct volume change between acute and subacute diffusion-weighted MRI ( r ≥0.60, P <0.01), acute and outcome MRI ( r =0.56, P =0.01), outcome National Institutes of Health Stroke Scale (NIHSS; r ≥0.53, P <0.02), and outcome modified Rankin Scale (mRS; r ≥0.53, P =0.02). Acute and final infarct volume change and outcome NIHSS and mRS were significantly higher in patients with mean CGMS or mean BGL glucose ≥7 mmol/L. Multiple regression analysis indicated that both mean CGMS and BGL glucose levels ≥7 mmol/L were independently associated with increased final infarct volume change. Conclusions— Persistent hyperglycemia on serial glucose monitoring is an independent determinant of infarct expansion and is associated with worse functional outcome. There is an urgent need to study normalization of blood glucose after stroke.

18 June 2002 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
MPMark W. Parsons
Mark W. Parsons
PBP. Alan Barber
P. Alan Barber
PDPatricia M. Desmond
Patricia M. Desmond
TBTracey A. Baird
Tracey A. Baird
DDDavid G. Darby
David G. Darby
SDStephen M. Davis
Stephen M. Davis

1 August 2007 in Stroke
Verified
Journal Article
Closed access
JPJane Prosser
Jane Prosser
LMLachlan MacGregor
Lachlan MacGregor
KLKennedy R. Lees
Kennedy R. Lees
HDHans-Christoph Diener
Hans-Christoph Diener
WHWerner Hacke
Werner Hacke
SDStephen Davis
Stephen Davis
Background and Purpose— In the first 3 months after acute ischemic stroke, 2% to 6% of patients die from cardiac causes. This may reflect preexisting cardiac disease, cardiac dysfunction related to the acute neurohumoral and autonomic stress response to stroke, or both. Delineation of a high-risk group could facilitate prevention strategies. We aimed to describe the temporal profile of cardiac risk after stroke and develop a predictive model of serious cardiac adverse events (SCAEs) using baseline variables. Methods— We used data from the one trial in the Virtual International Stroke Trials Archive that matched prespecified criteria. Survival analysis was used to describe the temporal profile of cardiac events after stroke. Prognostic determinants were assessed with multivariable logistic regression, and a risk score was derived from the key predictor variables. Results— Of 846 ischemic stroke patients, 35 (4.1%) died from cardiac causes and 161 (19.0%) suffered at least one SCAE. The hazard of cardiac death was highest (0.001/d) in the second week. Hazard of a first SCAE peaked at 0.02/d between day 2 and 3. The 5 factors most predictive of SCAEs were a history of heart failure (OR 3.33 [2.28, 4.89], P <0.001), diabetes (OR 2.11 [1.39, 3.21], P 115μmol/L (OR 1.77 [1.16, 2.70], P =0.008), severe stroke (OR 1.98 [1.34,2.91], P =0.001), and a long QTc or ventricular extrasystoles on ECG (OR 1.93 [1.31, 2.85], P =0.001). Risk of SCAEs ranged from 6.3% (no predictors) to 62.2% (≥4 predictors). Conclusion— Serious cardiac events are common in the acute period after stroke. Patients at highest risk are identifiable and may benefit from more aggressive strategies to improve survival.

1 April 2009 in Stroke
Verified
Journal Article
Closed access
CBChristen D. Barras
Christen D. Barras
BTBrian M. Tress
Brian M. Tress
SCSoren Christensen
Soren Christensen
LMLachlan MacGregor
Lachlan MacGregor
MCMarnie Collins
Marnie Collins
SDStephen M. Davis
Stephen M. Davis
Background and Purpose— Intracerebral hemorrhage (ICH) growth predicts mortality and functional outcome. We hypothesized that irregular hematoma shape and density heterogeneity, reflecting active, multifocal bleeding or a variable bleeding time course, would predict ICH growth. Methods— Three raters examined baseline sub-3-hour CT brain scans of 90 patients in the placebo arm of a Phase IIb trial of recombinant activated Factor VII in ICH. Each rater, blinded to growth data, independently applied novel 5-point categorical scales of density and shape to randomly presented baseline CT images of ICH. Density and shape were defined as either homogeneous/regular (Category 1 to 2) or heterogeneous/irregular (Category 3 to 5). Within- and between-rater reliability was determined for these scales. Growth was assessed as a continuous variable and using 3 binary definitions: (1) any ICH growth; (2) ≥33% or ≥12.5 mL ICH growth; and (3) radial growth >1 mm between baseline and 24-hour CT scan. Patients were divided into tertiles of baseline ICH volume: “small” (0 to 10 mL), “medium” (10 to 25 mL), and “large” (25 to 106 mL). Results— Inter- and intrarater agreements for the novel scales exceeded 85% (±1 category). Median growth was significantly higher in the large-volume group compared with the small group ( P <0.001) and in heterogeneous compared with homogeneous ICH ( P =0.008). Median growth trended higher in irregular ICHs compared with regular ICHs ( P =0.084). Small ICHs were more regularly shaped (43%) than medium (17%) and large (3%) ICHs ( P <0.001). Small ICHs were more homogeneous (73%) compared with medium (37%) and large (17%) ICHs ( P <0.001). Adjusting for baseline ICH volume and time to scan, density heterogeneity, but not shape irregularity, independently predicted ICH growth ( P =0.046) on a continuous growth scale. Conclusions— Large ICHs were significantly more irregular in shape, heterogeneous in density, and had greater growth. Density heterogeneity independently predicted ICH growth using some definitions.